Institut of Oncology Al. Trestioreanu Bucharest; Oncology Department

Bucharest 022328

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy — Stopped early